MYLS22

306959-01-3

CN1N (C (=O) C (=C1C) NC (=O) C2=CC3=C (S2) [N] (N=C3C) C4=CC=CC=C4) C5=CC=CC=C5

C24H21N5O2S

MYLS22 is a first-in-class and selective inhibitor of optic atrophy 1 (OPA1) with anti-angiogenesis and anti-cancer activity.

3 years -20°C powder